Viracta Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that company...

Related Keywords

Ashleigh Barreto ,Viracta Therapeutics Inc ,Nasdaq ,Viracta Therapeutics ,Annual Needham Virtual Healthcare Conference ,Relations Contact ,Investor Relations ,Nc ,